Outset Medical Q1 2024 Adj EPS $(0.57) Misses $(0.55) Estimate, Sales $28.168M Miss $30.341M Estimate
Portfolio Pulse from Benzinga Newsdesk
Outset Medical (NASDAQ:OM) reported Q1 2024 earnings with an adjusted EPS of $(0.57), missing the $(0.55) estimate, and sales of $28.168M, missing the $30.341M estimate. This represents a 20.83% increase in EPS losses and a 15.83% decrease in sales compared to the same period last year.
May 08, 2024 | 8:45 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Outset Medical reported a larger than expected loss per share and a miss in sales for Q1 2024, indicating a challenging quarter.
Missing both EPS and sales estimates typically leads to negative investor sentiment in the short term. The reported increase in losses and decrease in sales year-over-year further exacerbate concerns, likely leading to downward pressure on the stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100